Aging-associated insulin resistance predisposes to hypertension and its reversal by exercise: The role of vascular vasorelaxation to insulin

Basic Research in Cardiology

Volumn 104, Issue 3, 2009, Pages 269-284

  Li, Qiu Xia ^a,b   Xiong, Zheng Ying ^a,b   Hu, Bai Ping ^a   Tian, Zhen Jun ^a   Zhang, Hai Feng ^b   Gou, Wen Yi ^b   Wang, Hai Chang ^a   Gao, Feng ^b   Zhang, Quan Jiang ^a,b  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endothelialdys function; Exercise; Hypertension; Insulin resistance

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOPROTEIN GP 91; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; EXERCISE; HEART CONTRACTION; HYPERTENSION; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VASODILATATION;

AGING; ANIMALS; ARTERIES; BLOOD PRESSURE; BLOTTING, WESTERN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN RESISTANCE; MALE; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 64949129597     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-008-0754-8     Document Type: Article

References (47)

1. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252
2. Barbagallo M, Resnick LM, Dominguez LJ, Licata G (1997) Diabetes mellitus, hypertension and ageing: The ionic hypothesis of ageing and cardiovascular-metabolic diseases. Diabetes Metab 23:281-294
3. Blackwell KA, Sorenson JP, Richardson DM, Smith LA, Suda O, Nath K, Katusic ZS (2004) Mechanisms of aging-induced impairment of endothelium-dependent relaxation: Role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 287:2448-2453
4. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6:1362-1367
5. Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley G (2002) Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 90:1159-1166
6. Dengel DR, Hagberg JM, Pratley RE, Rogus EM, Goldberg AP (1998) Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men. Metabolism 47:1075-1082
7. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, Scherrer U (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342-345
8. Edwards JG, Tipton CM (1989) Influences of exogenous insulin on arterial blood pressure measurements of the rat. J Appl Physiol 67:2335-2342
9. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process? Diabetes 51:2951-2958
10. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R (2000) A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87:26-32
11. Grandi AM, Gaudio G, Fachinetti A, Zanzi P, Bianchi L, Ceriani L, Guasti L, Venco A (1997) Influence of family history of hypertension on insulin sensitivity in lean and obese hypertensive subjects. Eur J Clin Invest 27:774-779
12. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES (2003) Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26:2119-2125
13. Hu FB, Stampfer MJ (2005) Insulin resistance and hypertension: The chicken-egg question revisited. Circulation 112:1678-1680
14. Kelley GA, Kelley KS (2000) Progressive resistance exercise and resting blood pressure: A meta-analysis of randomized controlled trials. Hypertension 35:838-843
15. Kern W, Peters A, Born J, Fehm HL, Schultes B (2005) Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia. Metabolism 54:391-396
16. Keymel S, Kalka C, Rassaf T, Yeghiazarians Y, Kelm M, Heiss C (2008) Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res Cardiol [Epub ahead of print]
17. Kosegawa I, Katayama S, Kikuchi C, Kashiwabara H, Negishi K, Ishii J, Inukai K, Oka Y (1996) Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance. Hypertens Res 19:37-41
18. Lakatta EG, Levy D (2003) Arterial and cardiac aging: Major shareholders inAcardiovAscular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 107:139-146
19. Lauer T, Heiss C, Balzer J, Kehmeier E, Mangold S, Leyendecker T, Rottler J, Meyer C, Merx MW, Kelm M, Rassaf T (2008) Age-dependent endothelial dysfunction is associated with failure to increase plasma nitrite in response to exercise. Basic Res Cardiol 103:291-297
20. Li D, Qu Y, Tao L, Liu H, Hu A, Gao F, Sharifi-azad S, Grunwald Z, Ma XL, Sun JZ (2006) Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. J Surg Res 131:64-72
21. Ma H, Zhang HF, Yu L, Zhang QJ, Li J, Huo JH, Li X, Guo WY, Wang HC, Gao F (2006) Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: Role of Akt-stimulated NO production. Cardiovasc Res 69:57-65
22. Massion PB, Feron O, Dessy C, Balligand JL (2003) Nitric oxide and cardiac function: Ten years after, and continuing. Circ Res 93:388-398
23. Miyazaki Y, Hirata A, Murakami H, Fukuoka M, Agata J, Higashiura K, Masuda A, Ura N, Shimamoto K (1998) Effects of aging on the insulin actions for the glucose metabolism and renal function in normotensives and essential hypertensives. Am J Hypertens 11:1056-1064
24. Mulders AC, Mathy MJ, Meyer ZH, Ter BM, Hajji N, Olthof DC, Michel MC, Alewijnse AE, Peters SL (2008) Activation of sphingosine kinase by muscarinic receptors enhances NO-mediated and attenuates EDHF-mediated vasorelaxation. Basic Res Cardiol [Epub ahead of print]
25. Paolisso G, Gambardella A, Verza M, D'Amore A, Sgambato S, Varricchio M (1992) ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 6:175-179
26. Roberts CK, Vaziri ND, Barnard RJ (2002) Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 106:2530-2532
27. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, Benetos A (2006) Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 47:72-75
28. Saito I, Nishino M, Kawabe H, Wainai H, Hasegawa C, Saruta T, Nagano S, Sekihara T (1992) Leisure time physical activity and insulin resistance in young obese students with hypertension. Am J Hypertens 5:915-918
29. Schulman IH, Zhou MS, Jaimes EA, Raij L (2007) Dissociation between metabolic and vascular insulin resistance in aging. Am J Physiol Heart Circ Physiol 293:853-859
30. Schutzer WE, Reed JF, Mader SL (2005) Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. Am J Physiol Heart Circ Physiol 288:2457-2464
31. Sengstock DM, Vaitkevicius PV, Supiano MA (2005) Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults. J Clin Endocrinol Metab 90:2823-2827
32. Sowers JR (1997) Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 29:691-699
33. Sowers JR (2004) Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 286:1597-1602
34. Sowers JR, Haffner S (2002) Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. Hypertension 40:781-788
35. Sun MW, Qian FL, Wang J, Tao T, Guo J, Wang L, Lu AY, Chen H (2008) Low-intensity voluntary running lowers blood pressure with simultaneous improvement in endothelium-dependent vasodilatation and insulin sensitivity in aged spontaneously hypertensive rats. Hypertens Res 31:543-552
36. Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA, Ma XL, Batinic-haberle I, Willette RN, Ohlstein EH, Yue TL (2003) Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Circulation 108:2805-2811
37. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK (2003) Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107: 3109-3116
38. Whelton SP, Chin A, Xin X, He J (2002) Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med 136:493-503
39. White MF (2003) Insulin signaling in health and disease. Science 302:1710-1711
40. Wisloff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-share Q, Fernstrom M, Rezaei K, Lee SJ, Koch LG, Britton SL (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307:418-420
41. Wojtaszewski JF, Hansen BF, Gade, Kiens B, Markuns JF, Goodyear LJ, Richter EA (2000) Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 49:325-331
42. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, Sessa WC (2006) Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest 116:1284-1291
43. Yusuf S, Ostergren JB, Gerstein HC, Pfeffer MA, Swedberg K, Granger CB, Olofsson B, Probstfield J, Mcmurray JV (2005) Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation 112:48-53
44. Zhang C (2008) The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 103:398-406
45. Zhang C, Park Y, Picchi A, Potter BJ (2008) Maturation-induces endothelial dysfunction via vascular inflammation in diabetic mice. Basic Res Cardiol 103:407-416
46. Zhang H, Li J, Li R, Zhang Q, Ma H, Ji Q, Guo W, Wang H, Lopez BL, Christopher TA, Ma X, Gao F (2008) Reduced cardiotropic response to insulin in spontaneously hypertensive rats: Role of peroxisome proliferator-activated receptor-gamma-initiated signaling. J Hypertens 26:560-569
47. Zhang QJ, Li QX, Zhang HF, Zhang KR, Guo WY, Wang HC, Zhou Z, Cheng HP, Ren J, Gao F (2007) Swim training sensitizes myocardial response to insulin: Role of Akt-dependent eNOS activation. Cardiovasc Res 75:369-380